| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/16/2007 | US20070190569 Detecting molecules |
| 08/16/2007 | US20070190561 Nucleotide sequences coding polymerase for use in identifying modulators to treat cell proliferative disorders; enzyme inhibitors; antitumor agents |
| 08/16/2007 | US20070190550 Novel compositions and methods for the identification, assessment, prevention, and therapy of human cancers |
| 08/16/2007 | US20070190524 Non-M, non-O HIV-1 strains, fragments and uses |
| 08/16/2007 | US20070190077 Anti-HIV agents |
| 08/16/2007 | US20070190060 Passive targeting of cytotoxic agents |
| 08/16/2007 | US20070190057 Methods for modulating mannose content of recombinant proteins |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | US20070190053 Treament of lupus nephritis with anti-CD40L compounds |
| 08/16/2007 | US20070190051 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 08/16/2007 | US20070190049 Use of A33 antigens and JAM-IT |
| 08/16/2007 | US20070190046 Anti-abeta antibody |
| 08/16/2007 | US20070190045 Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity |
| 08/16/2007 | US20070190044 Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal |
| 08/16/2007 | US20070189982 Diagnostics and treatments of Periodontal disease |
| 08/16/2007 | US20070189981 Porphorymonas gingivalis polypeptides and nucleotides |
| 08/16/2007 | US20070189963 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 08/16/2007 | US20070189962 Mutated anti-cd22 antibodies and immunoconjugates |
| 08/16/2007 | CA2641555A1 Preferential inhibition of presenilin-1 |
| 08/16/2007 | CA2641455A1 Novel oxidoreductases and uses thereof |
| 08/16/2007 | CA2641169A1 Antigenic gm-csf peptides and antibodies to gm-csf |
| 08/16/2007 | CA2638889A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 08/16/2007 | CA2638849A1 Antibodies that bind par-2 |
| 08/16/2007 | CA2637775A1 Antibodies against secreted frizzled related protein-4 (sfrp-4 ) |
| 08/15/2007 | EP1818400A1 METHOD OF SITE-SPECIFICALLY INTRODUCING NON-NATURAL AMINO ACID INTO PROTEIN USING MITOCHONDRIAL PROTEIN AND METHOD FOR EFFECTIVELY PREPARING tRNA |
| 08/15/2007 | EP1818343A2 Antibodies against human IL-12 |
| 08/15/2007 | EP1818342A2 Purified primate CTLA-8 antigens and related reagents |
| 08/15/2007 | EP1818062A1 An anti HSP90 antibody |
| 08/15/2007 | EP1817584A2 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 08/15/2007 | EP1817345A2 Antibodies against tenascin-c |
| 08/15/2007 | EP1817344A2 ANTI-TNF ALPHA ANTIBODIES WHICH SELECTIVELY INHIBIT TNF ALPHA SIGNALLING THROUGH THE p55R |
| 08/15/2007 | EP1817343A1 Human monoclonal antibodies against human il-4 |
| 08/15/2007 | EP1817342A1 Method for affinity purification |
| 08/15/2007 | EP1817341A2 Engineered antibodies and immunoconjugates |
| 08/15/2007 | EP1817340A2 Fc variants with altered binding to fcrn |
| 08/15/2007 | EP1817327A1 Antigenic epitopes of interleukin-21, related antibodies and their use in medical field |
| 08/15/2007 | EP1817055A2 Ovr110 antibody compositions and methods of use |
| 08/15/2007 | EP1817054A1 Naturally occuring igm antibodies that bind lymphocytes |
| 08/15/2007 | EP1539822B1 Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells |
| 08/15/2007 | EP1255109B1 Screening method |
| 08/15/2007 | EP1108023B1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 08/15/2007 | EP1007670B1 Two human g-protein coupled receptors: ebv-induced gpcr 2 (ebi-2) and edg-1-like gpcr |
| 08/15/2007 | EP0981618B1 Anti-apo-2 antibody |
| 08/15/2007 | EP0935673B1 Methods and devices for mass transport assisted optical assays |
| 08/15/2007 | EP0876610B1 A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility |
| 08/15/2007 | EP0784684B1 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES |
| 08/15/2007 | CN1332032C Methods of expressing LIM mineralization protein in non-osseous cells |
| 08/15/2007 | CN1331888C Single strand double specificity anti-body resisting human B cell leucoma |
| 08/15/2007 | CN1331887C Lymphoma specific chimeric monoclonal antibody against HLA-DR10 |
| 08/15/2007 | CN1331886C Artificial antigen, antibody of fenvalerate and uses thereof |
| 08/15/2007 | CN1331877C Recombinant helicobacter pylori outer-membrane protein 25 |
| 08/15/2007 | CN1331876C Recombinant helicobacter pylori blood group antigen adhesin |
| 08/15/2007 | CN101019025A Busulfan immunoassay |
| 08/15/2007 | CN101019024A Taxol immunoassay method |
| 08/15/2007 | CN101018863A Mutant pneumolysin proteins |
| 08/15/2007 | CN101018810A Anti-synoviolin antibody |
| 08/15/2007 | CN101018809A Expression-enhanced polypeptides |
| 08/15/2007 | CN101018808A Compositions and methods for regulation of tumor necrosis factor-alpha |
| 08/15/2007 | CN101018565A Methods for treating conditions associated with MASP-2 dependent complement activation |
| 08/15/2007 | CN101016547A Method of preparing ocean double RNA virus MABV recombination albumen and application thereof |
| 08/15/2007 | CN101016543A In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 08/15/2007 | CN101016338A Preparing method for human lymphocyte immune globulin antibody raw material |
| 08/15/2007 | CN101016337A Preparing method of heavy metal cadmium monoclonal antibody |
| 08/14/2007 | US7256279 Protein having ribonucleotide reductase activity and DNA thereof |
| 08/14/2007 | US7256277 Nucleotide and protein sequence of mammastatin and methods of use |
| 08/14/2007 | US7256274 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 08/14/2007 | US7256273 Diagnosis of brain disorders; Alzheimer's disease; genetic engineered immunoglobulins |
| 08/14/2007 | US7256272 Separation of anticancer antibodies using cancer cell cytotoxicity; complexing antibodies; medical diagnosis |
| 08/14/2007 | US7256271 Cancerous disease modifying antibodies |
| 08/14/2007 | US7256270 Immunogen adherence inhibitor and method of making and using same |
| 08/14/2007 | US7256269 Immunogen adherence inhibitor and method of making and using same |
| 08/14/2007 | US7256267 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 08/14/2007 | US7256263 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies |
| 08/14/2007 | US7256253 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 08/14/2007 | US7256252 Methods for detecting cell apoptosis |
| 08/14/2007 | US7256039 PRO4405 nucleic acids |
| 08/14/2007 | US7256028 Methods for screening compounds that modulate lipid metabolism |
| 08/14/2007 | US7256017 Methods for generating lepidopteran-toxic polypeptides |
| 08/14/2007 | US7256004 Detecting tumor cells expressing TAG-72 using CC49 in which less than all six (three heavy chain and three light chain) Complementarity Determining Regions are present |
| 08/14/2007 | US7256001 Diagnosing malignacy and respiratory system disorder via concentration of extracellular matrix protein; immunodiagnostics |
| 08/14/2007 | US7255988 Use of α 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an ACT polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances |
| 08/14/2007 | US7255862 ALVAC/FIV constructs |
| 08/14/2007 | US7255860 Effective against resting pain, mechanically-induced pain and thermally-induced pain without inhibiting wound healing |
| 08/14/2007 | US7255859 Derived from the haemagglutinin of the human influenza virus and suitable for the detection and isolation of native haemagglutinin of the human influenza virus, of modified haemagglutinin or of haemagglutinin fusion proteins |
| 08/14/2007 | US7255858 Enhancing the efficacy of immunotherapies by supplementing with complement |
| 08/14/2007 | US7255855 Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase |
| 08/14/2007 | US7255854 Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases |
| 08/14/2007 | CA2166328C Prostacyclin synthase derived from human |
| 08/09/2007 | WO2007089871A2 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| 08/09/2007 | WO2007089690A2 Tat-042 and methods of assessing and treating cancer |
| 08/09/2007 | WO2007089659A2 Tat-039 and methods of assessing and treating cancer |
| 08/09/2007 | WO2007089563A2 Rabbit monoclonal antibodies against mouse/human id3 proteins |
| 08/09/2007 | WO2007089419A2 Sequence of stro-1 antibody variable region |
| 08/09/2007 | WO2007088823A1 ABZYME TO HUMAN TNF-α AND USE THEREOF |
| 08/09/2007 | WO2007088639A1 Substrate protein for m-phase kinase and use thereof |
| 08/09/2007 | WO2007088159A1 Methods of treating degenerative disorders with rac 1b inhibitor |
| 08/09/2007 | WO2007087679A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor v |
| 08/09/2007 | WO2007087673A1 Domain antibody construct |
| 08/09/2007 | WO2007068412A3 A beta 1-42 specific monoclonal antibodies with therapeutic properties |
| 08/09/2007 | WO2007068354A8 Means and methods for the treatment of tumorous diseases |